Tectonic Therapeutic
TECX· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -54.8% in FY2025
Alise Reicin, M.D. is the CEO of Tectonic Therapeutic and was paid $7.4M in FY2025 (Dec).
Pay$100 in the stock at the end of FY24 → $45
Executives3
See all- 1Alise Reicin, M.D.President, CEO and DirectorFY2025
- 2Daniel Lochner, M.B.A.Chief Financial OfficerFY2025
- 3Marcella K. Ruddy, M.D.Chief Medical OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allTectonic Therapeutic paid its 3 named executives $13.5M in total in FY2025 (Dec). CEO Alise Reicin, M.D. was paid $7.4M of that.
| Name | |||
|---|---|---|---|
| Alise Reicin, M.D.President, CEO and Director | Not disclosed | Not disclosed | |
| Daniel Lochner, M.B.A.Chief Financial Officer | Not disclosed | ||
| Marcella K. Ruddy, M.D.Chief Medical Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Tectonic Therapeutic. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board1
See all- Timothy A. SpringerDirector · 9 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings5
See all| Proxy statement | DEF 14A | Apr 24, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 25, 2025 | FY2024 |
| Annual report | 10-K | Mar 20, 2025 | FY2024 |
| Annual report | 10-K | Mar 14, 2024 | FY2023 |